| COVID-19 |
1 |
0.96 |
| Guillain-Barre Syndrome |
0 |
0.9 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.77 |
| Influenza |
0 |
0.67 |
| Vaccines |
0 |
0.63 |
| Acute Respiratory Distress Syndrome |
0 |
0.5 |
| COVID-19 Vaccine |
0 |
0.48 |
| Facial Nerve Paralysis |
0 |
0.39 |
| Immunization |
0 |
0.38 |
| Influenza Vaccine |
0 |
0.35 |
| Face |
0 |
0.32 |
| UK Site Content |
0 |
0.26 |
| NHS |
0 |
0.19 |
| Brachial |
0 |
0.13 |
| Europe |
0 |
0.13 |
| Nerve |
0 |
0.13 |
| Swine Flu |
0 |
0.13 |
| Weakness |
0 |
0.13 |
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
0 |
0.08 |
| Otolaryngology |
0 |
0.08 |
| Bacteria |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Neuropathy |
0 |
0.06 |
| Outbreak |
0 |
0.06 |
| Pandemic |
0 |
0.06 |
| Paresis |
0 |
0.06 |
| Quadriplegia |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Mechanical Ventilation |
0 |
0.04 |
| Spinal Cord Injury |
0 |
0.04 |
| Tropical Diseases |
0 |
0.04 |
| Zika Virus |
0 |
0.04 |